What happens in vivo to bacterial pathogens?
Smith
H
H
Medical School University of Birmingham, Edgbaston, UK.
D000818:Animals; D001419:Bacteria / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D001424:Bacterial Infections / Q000382:microbiology*; D003569:Cytidine Monophosphate N-Acetylneuraminic Acid / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial; D005798:Genes, Bacterial; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism; D008070:Lipopolysaccharides / Q000378:metabolism; D009344:Neisseria gonorrhoeae / Q000378:metabolism / Q000472:pathogenicity; D009345:Neisseria meningitidis / Q000378:metabolism / Q000472:pathogenicity; D012794:Sialic Acids / Q000378:metabolism; D014774:Virulence / Q000235:genetics
D008070:Lipopolysaccharides; D012794:Sialic Acids; D003569:Cytidine Monophosphate N-Acetylneuraminic Acid; D019344:Lactic Acid